Dr. Hoenle AG (DE:HNL)
XETRA:HNL
Want to see DE:HNL full AI Analyst Report?
HNL Stock Chart & Stats
€7.10
-€0.20(-2.86%)
At close: 4:00 PM EST
€7.10
-€0.20(-2.86%)
Day’s Range― - ―
52-Week Range€6.48 - €10.70
Previous CloseN/A
Volume3.05K
Average Volume (3M)6.13K
Market Cap
€57.22M
Enterprise Value€98.44M
Total Cash (Recent Filing)€7.04M
Total Debt (Recent Filing)€48.01M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding6,062,930
10 Day Avg. Volume3,193
30 Day Avg. Volume6,130
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.65
Price to Sales (P/S)0.53
P/FCF Ratio15.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€99.60M
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationSustained positive operating and free cash flow signals the business can self-fund working capital and incremental investment without relying solely on external financing. Over 2–6 months this supports operational stability, funds replacement parts inventories for recurring revenue, and provides limited capacity for strategic spend or debt paydown.
Manageable Leverage And Meaningful EquityA moderate debt-to-equity ratio and a meaningful equity base provide financial flexibility and lower refinancing risk compared with heavily leveraged peers. This structural balance-sheet position supports multi-month resilience to cyclical demand, enabling investment in product development and servicing the installed base without excessive solvency pressure.
Recurring Revenue From Installed Base And ConsumablesA business model tied to equipment plus consumables, service and measurement creates durable, repeatable revenue streams. Installed-base-driven spares and validation equipment reduce revenue volatility and increase customer stickiness, supporting predictable cash flows and longer-term margin sustainability as customers standardize on Hönle systems.
Bears Say
Multi-year Revenue DeclineA persistent revenue downtrend indicates structural demand or market-share challenges that are unlikely to reverse immediately. Continued contraction reduces operating leverage, restrains reinvestment capacity, and makes it harder to restore sustained profitability without clear new product wins or market expansion initiatives over the coming months.
Negative Net And EBIT MarginsPersisting negative net and EBIT margins mean the company is not yet converting core operations into consistent bottom-line profits. This limits retained earnings, constrains balance-sheet repair and reduces investment ability. Without structural margin expansion, earnings volatility and reliance on cost control will remain key risks over months ahead.
Limited Deleveraging CapacityAlthough cash flow has improved, its current scale relative to debt restricts meaningful deleveraging. This structural constraint reduces headroom for larger M&A, R&D investment or buffer against demand shocks. Meaningful balance-sheet improvement requires sustained higher cash generation or external capital, which may take multiple quarters.
Dr. Hoenle AG News
HNL FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest stock price was €6.48 and its highest was €10.70 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €57.22M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is Aug 18, 2026 which is in 73 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on May 19, 2026. The company reported €0.11 earnings per share for the quarter, the consensus estimate of €0.11 by €0.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of €0.11 in its last earnings report, expectations of €0.11. Following the earnings report the stock price went up 0.846%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in DE:HNL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Hoenle AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.44%
12-Months-Change
Fundamentals
Return on Equity
-4.69%
Trailing 12-Months
Asset Growth
-5.37%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
Technical Analysis
LPKF Laser & Electronics
―
Manz AG
―
MAX Automation
―
Singulus Technologies
―
Suss Microtec
―
Options Prices
Currently, No data available
---